The US Patent and Trademark Office is holding two hearings — one this week and other in March — to gather information on "independent second opinion genetic diagnostic testing" on genes that are already patented or exclusively licensed by other companies, reports Patent Docs' Donald Zuhn. USPTO is planning to gather the information it receives from the hearings and make a report to Congress.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.